0001213900-21-034018.txt : 20210624 0001213900-21-034018.hdr.sgml : 20210624 20210624180053 ACCESSION NUMBER: 0001213900-21-034018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210622 FILED AS OF DATE: 20210624 DATE AS OF CHANGE: 20210624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tesi Raymond Joseph CENTRAL INDEX KEY: 0001767280 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 211043998 MAIL ADDRESS: STREET 1: 476 MASSACHUSETTS AVE, UNIT 2 CITY: BOSTON STATE: MA ZIP: 02118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0306 4 2021-06-22 0 0001711754 Inmune Bio, Inc. INMB 0001767280 Tesi Raymond Joseph C/O INMUNE BIO INC., 1200 PROSPECT STREET, SUITE 525 LA JOLLA, CA 92037 1 1 1 0 President & CEO Option 17.49 2021-06-22 4 A 0 70663 0 A 2031-06-22 Common Stock 70663 70663 D Each Option represents a right to receive one share of common stock of INmune Bio, Inc. Options granted pursuant to 2021 Stock Incentive Plan. Twenty-five percent of the Option will vest 12 months from the date of grant and thereafter the remaining unvested Option will become vested and exercisable pro rata on a monthly basis over three (3) years (1/36 per month) until the Option is 100% vested which shall occur on the four-year anniversary of the date of grant. /s/ Raymond J. Tesi 2021-06-24